{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:12:23Z","timestamp":1787008343971,"version":"build-2736575974"},"reference-count":27,"publisher":"Society of Nuclear Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.2967\/jnumed.118.217539","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T14:06:26Z","timestamp":1541167586000},"page":"348-352","source":"Crossref","is-referenced-by-count":22,"title":["Hexokinase-2 Expression in <sup>11<\/sup>C-Methionine\u2013Positive, <sup>18<\/sup>F-FDG\u2013Negative Multiple Myeloma"],"prefix":"10.2967","volume":"60","author":[{"given":"Stefan","family":"Kircher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Stolzenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus Martin","family":"Kort\u00fcm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Kircher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Da Via","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Samnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas K.","family":"Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Einsele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Lapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2018,11,2]]},"reference":[{"key":"2021051712130238000_60.3.348.1","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/S1470-2045(17)30189-4","article-title":"Role of 18F-FDG PET\/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group","volume":"18","author":"Cavo","year":"2017","journal-title":"Lancet Oncol."},{"key":"2021051712130238000_60.3.348.2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-361386"},{"key":"2021051712130238000_60.3.348.3","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/leu.2015.291","article-title":"18F-FDG PET\/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease","volume":"30","author":"Zamagni","year":"2016","journal-title":"Leukemia."},{"key":"2021051712130238000_60.3.348.4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-03-213280"},{"key":"2021051712130238000_60.3.348.5","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1200\/JCO.2017.72.2975","article-title":"Prospective evaluation of magnetic resonance imaging and [18F]fluorodeoxyglucose positron emission tomography-computed tomography at diagnosis and before maintenance therapy in symptomatic patients with multiple myeloma included in the IFM\/DFCI 2009 trial: results of the IMAJEM study","volume":"35","author":"Moreau","year":"2017","journal-title":"J Clin Oncol."},{"key":"2021051712130238000_60.3.348.6","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.18632\/oncotarget.2290","article-title":"18 FDG-PET\/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation","volume":"5","author":"Lapa","year":"2014","journal-title":"Oncotarget."},{"key":"2021051712130238000_60.3.348.7","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1007\/s00259-018-3997-0","article-title":"Prognostic value of [18F]FDG-PET\/CT in multiple myeloma patients before and after allogeneic hematopoietic cell transplantation","volume":"45","author":"Stolzenburg","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712130238000_60.3.348.8","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26467"},{"key":"2021051712130238000_60.3.348.9","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10554"},{"key":"2021051712130238000_60.3.348.10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-774422"},{"key":"2021051712130238000_60.3.348.11","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-5-68"},{"key":"2021051712130238000_60.3.348.12","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s00259-016-3392-7","article-title":"18F-fluorocholine versus 18F-fluorodeoxyglucose for PET\/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study","volume":"43","author":"Cassou-Mounat","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712130238000_60.3.348.13","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.131169"},{"key":"2021051712130238000_60.3.348.14","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2422051980"},{"key":"2021051712130238000_60.3.348.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-012-2333-3"},{"key":"2021051712130238000_60.3.348.16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.7150\/thno.13921","article-title":"11C-methionine-PET in multiple myeloma: correlation with clinical parameters and bone marrow involvement","volume":"6","author":"Lapa","year":"2016","journal-title":"Theranostics."},{"key":"2021051712130238000_60.3.348.17","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.7150\/thno.20491","article-title":"C-11-methionine-PET in multiple myeloma: a combined study from two different institutions","volume":"7","author":"Lapa","year":"2017","journal-title":"Theranostics."},{"key":"2021051712130238000_60.3.348.18","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.18632\/oncotarget.3053","article-title":"C-11-methionine-PET: a novel and sensitive tool for monitoring of early response to treatment in multiple myeloma","volume":"6","author":"L\u00fcckerath","year":"2015","journal-title":"Oncotarget."},{"key":"2021051712130238000_60.3.348.19","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/bjh.14696","article-title":"[11C]methionine emerges as a new biomarker for tracking active myeloma lesions","volume":"181","author":"Lapa","year":"2018","journal-title":"Br J Haematol."},{"key":"2021051712130238000_60.3.348.20","first-page":"138","article-title":"Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue [in German]","volume":"8","author":"Remmele","year":"1987","journal-title":"Pathologe."},{"key":"2021051712130238000_60.3.348.21","first-page":"1811","article-title":"In vivo assessment of glucose metabolism in hepatocellular carcinoma with FDG-PET","volume":"36","author":"Torizuka","year":"1995","journal-title":"J Nucl Med."},{"key":"2021051712130238000_60.3.348.22","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00259-017-3656-x","article-title":"The gross picture: intraindividual tumour heterogeneity in a patient with nonsecretory multiple myeloma","volume":"44","author":"Lapa","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021051712130238000_60.3.348.23","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41467-017-00296-y","article-title":"Spatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing","volume":"8","author":"Rasche","year":"2017","journal-title":"Nat Commun."},{"key":"2021051712130238000_60.3.348.24","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3997"},{"key":"2021051712130238000_60.3.348.25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.57.9961"},{"key":"2021051712130238000_60.3.348.26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7150\/thno.16576","article-title":"[68Ga]pentixafor-PET\/CT for imaging of chemokine receptor CXCR4 expression in multiple myeloma: comparison to [18F]FDG and laboratory values","volume":"7","author":"Lapa","year":"2017","journal-title":"Theranostics."},{"key":"2021051712130238000_60.3.348.27","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201404698"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.118.217539","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T20:35:32Z","timestamp":1621283732000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.118.217539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,2]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,1]]},"published-print":{"date-parts":[[2019,3]]}},"alternative-id":["10.2967\/jnumed.118.217539"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.118.217539","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,2]]}}}